- Home
- Eurosurveillance
- Volume 29,Issue 40, 03/Oct/2024
- Article
Research Open Access
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.40.2300739
Like 0
Access full text Article
Download
- Brechje de Gier1, Jan van de Kassteele1, Liselotte van Asten1, Annelot F Schoffelen1, ISIS-AR study group2, Mariette Hooiveld3, Margreet JM te Wierik1, Nina M van Sorge4,5, Hester E de Melker1
View AffiliationsHide Affiliations
Affiliations:
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
2The members of the ISIS-AR study group are listed under Collaborators.
3Nivel, Utrecht, the Netherlands
4Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam University Medical Center location AMC, Amsterdam, the Netherlands
5Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
Correspondence:
Brechje de Gier
brechje.de.gierrivm.nl
- View Collaborators
Members of the ISIS-AR study group:JWT Cohen Stuart,DC Melles,K van Dijk,A Alzubaidy,M Scholing,SD Kuil,GJ Blaauw,W Altorf van der Kuil,SM Bierman,SC de Greeff,SR Groenendijk,R Hertroys,JCM Monen,DW Notermans,J Polman,WJ van den Reek,C Schneeberger-van der Linden,F Velthuis,CCH Wielders,BJ de Wit,RE Zoetigheid,W van den Bijllaardt,EM Kraan,MB Haeseker,JM da Silva,E de Jong,B Maraha,AJ van Griethuysen,BB Wintermans,MJCA van Trijp,AE Muller,M Wong,A Ott,E Bathoorn,M Lokate,J Sinnige,DC Melles,N Plantinga,NH Renders,JW Dorigo-Zetsma,LJ Bakker,K Waar,MT van der Beek,MA Leversteijn-van Hall,SP van Mens,E Schaftenaar,MH Nabuurs-Franssen,I Maat,PDJ Sturm,BMW Diederen,LGM Bode,DSY Ong,M van Rijn,S Dinant,M den Reijer,DW van Dam,EIGB de Brauwer,RG Bentvelsen,AGM Buiting,ALM Vlek,M de Graaf,A Troelstra,AR Jansz,MPA van Meer,J de Vries,JD Machiels
View CitationHide Citation
Citation style for this article:de Gier Brechje, van de Kassteele Jan, van Asten Liselotte, Schoffelen Annelot F, ISIS-AR study group, Hooiveld Mariette, te Wierik Margreet JM, van Sorge Nina M, de Melker Hester E.Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.Euro Surveill. 2024;29(40):pii=2300739.https://doi.org/10.2807/1560-7917.ES.2024.29.40.2300739Received: 21 Dec 2023;Accepted: 31 Jul 2024
- Previous Article
- Table of Contents
- Next Article
Abstract
Background
After most COVID-19 pandemic control measures were lifted in 2022, many infectious diseases re-emerged. An increase in invasive group A streptococcal (iGAS) infections among adults and young children was reported by several countries. Viral infections including influenza and varicella, known risk factors for iGAS infection, also increased.
Aim
To estimate the proportion of GAS skin and soft tissue infections (SSTI) and pneumonia/sepsis in children (≤ 5 years) attributable to varicella, and the proportion of GAS pneumonia/sepsis in children and adults attributable to potentially predisposing respiratory viruses influenza A and B, RSV, hMPV and SARS-CoV-2 in the Netherlands.
Methods
We performed time series regression using weekly data on respiratory viruses, varicella and non-invasive GAS infections and GAS isolates cultured from blood, lower airways, skin, pus and wounds, from January 2010 to March 2023.
Results
In 2010–19, 50% (95% CI: 36–64) of GAS SSTI in children were attributable to varicella. Between January 2022 and March 2023, 34% (95% CI: 24–43) of GAS SSTI cases were attributable to varicella. Of iGAS pneumonia/sepsis between January 2022 and March 2023, 34% (95% CI: 20–49) and 25% (95% CI: 18–32) was attributable to respiratory virus infections in children and adults, respectively, with the largest contributor (17%) being influenza A.
Conclusions
Predisposing viral infections likely contributed to, but cannot fully explain, the observed iGAS increase among children and adults in 2022–23 in the Netherlands. Public health measures to control viral infections, such as vaccination against varicella or influenza, might reduce the iGAS disease burden.
©
This work is licensed under a Creative Commons Attribution 4.0 International License.
Article metrics loading...
/content/10.2807/1560-7917.ES.2024.29.40.2300739
2024-10-03
2024-11-16
Click here for cited by
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.40.2300739
Full text loading...
/deliver/fulltext/eurosurveillance/29/40/eurosurv-29-40-4.html?itemId=/content/10.2807/1560-7917.ES.2024.29.40.2300739&mimeType=html&fmt=ahah
References
de Gier B, Marchal N, de Beer-Schuurman I, Te Wierik M, Hooiveld M, de Melker HE, et al. Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill. 2023;28(1):2200941. https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200941PMID: 36695447
European Centre for Disease Prevention and Control (ECDC). Increase in invasive group A streptococcal infections among children in Europe, including fatalities. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/news-events/increase-invasive-group-streptococcal-infections-among-children-europe-including
Guy R, Henderson KL, Coelho J, Hughes H, Mason EL, Gerver SM, et al. Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. 2023;28(1):2200942. https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200942PMID: 36695450
Lassoued Y, Assad Z, Ouldali N, Caseris M, Mariani P, Birgy A, et al. Unexpected increase in invasive group A streptococcal infections in children after respiratory viruses outbreak in France: a 15-year time-series analysis. Open Forum Infect Dis. 2023;10(5):ofad188. https://doi.org/10.1093/ofid/ofad188PMID: 37180594
Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, Melo-Cristino J, et al. Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023. Euro Surveill. 2023;28(36):2300427. https://doi.org/10.2807/1560-7917.ES.2023.28.36.2300427PMID: 37676143
Cobo-Vazquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J, PedGAS-net Working Group. Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019-2022. Lancet Reg Health Eur. 2023;27:100597. https://doi.org/10.1016/j.lanepe.2023.100597PMID: 36895202
Nygaard U, Hartling UB, Munkstrup C, Nielsen AB, Dungu KHS, Schmidt LS, et al. Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study. Lancet Child Adolesc Health. 2024;8(2):112-21. https://doi.org/10.1016/S2352-4642(23)00295-XPMID: 38103567
Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics. 2000;105(5):E60. https://doi.org/10.1542/peds.105.5.e60PMID: 10799624
Imöhl M, van der Linden M, Reinert RR, Ritter K. Invasive group A streptococcal disease and association with varicella in Germany, 1996-2009. FEMS Immunol Med Microbiol. 2011;62(1):101-9. https://doi.org/10.1111/j.1574-695X.2011.00788.xPMID: 21314732
Herrera AL, Huber VC, Chaussee MS. The association between invasive group A streptococcal diseases and viral respiratory tract infections. Front Microbiol. 2016;7:342. https://doi.org/10.3389/fmicb.2016.00342PMID: 27047460
de Gier B, Vlaminckx BJM, Woudt SHS, van Sorge NM, van Asten L. Associations between common respiratory viruses and invasive group A streptococcal infection: A time-series analysis. Influenza Other Respir Viruses. 2019;13(5):453-8. https://doi.org/10.1111/irv.12658PMID: 31237087
van Kempen EB, Bruijning-Verhagen PCJ, Borensztajn D, Vermont CL, Quaak MSW, Janson JA, et al. Increase in invasive group A streptococcal infections in children in the Netherlands, a survey among 7 hospitals in 2022. Pediatr Infect Dis J. 2023;42(4):e122-4. https://doi.org/10.1097/INF.0000000000003810PMID: 36728741
Altorf-van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, et al. National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands. Euro Surveill. 2017;22(46):17-00062. https://doi.org/10.2807/1560-7917.ES.2017.22.46.17-00062PMID: 29162208
Nivel. Actuele Weekcijfers Aandoeningen- Surveillance. Utrecht: Nivel; 2023. Available from: https://www.nivel.nl/nl/zorg-en-ziekte-in-cijfers/actuele-cijfers-ziekten-per-week
World Health Organization (WHO). International Classification of Primary Care, 2nd edition (ICPC-2). Geneva: WHO; 2024. Available from: https://www.who.int/standards/classifications/other-classifications/international-classification-of-primary-care
De Gier B, Nijsten DRE, Duijster JW, Hahne SJM. Virological surveillance in the Netherlands- Virological weekly reports. State of Infectious Diseases in the Netherlands, 2016. RIVM Report 2017-0029/2017. Bilthoven: RIVM; 2017. Available from: https://www.rivm.nl/bibliotheek/rapporten/2017-0029.pdf
van Boven M, Hetebrij WA, Swart A, Nagelkerke E, van der Beek RF, Stouten S, et al. Patterns of SARS-CoV-2 circulation revealed by a nationwide sewage surveillance programme, the Netherlands, August 2020 to February 2022. Euro Surveill. 2023;28(25):2200700. https://doi.org/10.2807/1560-7917.ES.2023.28.25.2200700PMID: 37347416
Eilers PHC, Marx BD. Flexible smoothing with B-splines and penalties. Stat Sci. 1996;11(2):89-121. https://doi.org/10.1214/ss/1038425655
Scheipl F. spikeSlabGAM: bayesian variable selection, model choice and regularization for generalized additive mixed models in R. J Stat Softw. 2011;43(14):1-24. https://doi.org/10.18637/jss.v043.i14
Gasparrini A. Distributed Lag Linear and Non-Linear Models in R: The Package dlnm. J Stat Softw. 2011;43(8):1-20. https://doi.org/10.18637/jss.v043.i08PMID: 22003319
R Foundation for Statistical Computing. R: A language and environment for statistical computing. Vienna: R Core Team; 2022. Available from: https://www.R-project.org
Stan Development Team. RStan: the R interface to Stan. R package version 2.21.8. 2023. Available from: https://mc-stan.org
Davies PJB, Russell CD, Morgan AR, Taori SK, Lindsay D, Ure R, et al. Increase of severe pulmonary infections in adults caused by M1(UK) Streptococcus pyogenes, Central Scotland, UK. Emerg Infect Dis. 2023;29(8):1638-42. https://doi.org/10.3201/eid2908.230569PMID: 37343545
Holdstock V, Twynam-Perkins J, Bradnock T, Dickson EM, Harvey-Wood K, Kalima P, et al. National case series of group A streptococcus pleural empyema in children: clinical and microbiological features. Lancet Infect Dis. 2023;23(2):154-6. https://doi.org/10.1016/S1473-3099(23)00008-7PMID: 36634683
Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19(11):1209-18. https://doi.org/10.1016/S1473-3099(19)30446-3PMID: 31519541
Rümke LW, de Gier B, Vestjens SMT, van der Ende A, van Sorge NM, Vlaminckx BJM, et al. Dominance of M1UK clade among Dutch M1 Streptococcus pyogenes. Lancet Infect Dis. 2020;20(5):539-40. https://doi.org/10.1016/S1473-3099(20)30278-4PMID: 32359464
Rümke LW, Davies MA, Vestjens SMT, van der Putten BCL, Bril-Keijzers WCM, van Houten MA, et al. Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study. J Clin Microbiol. 2024;e0076624.; Epub ahead of print. https://doi.org/10.1128/jcm.00766-24PMID: 39194268
Davies MR, Keller N, Brouwer S, Jespersen MG, Cork AJ, Hayes AJ, et al. Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun. 2023;14(1):1051. https://doi.org/10.1038/s41467-023-36717-4PMID: 36828918
Johannesen TB, Munkstrup C, Edslev SM, Baig S, Nielsen S, Funk T, et al. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill. 2023;28(26):2300291. https://doi.org/10.2807/1560-7917.ES.2023.28.26.2300291PMID: 37382884
Heins M, Korevaar J, Knottnerus B, Hooiveld M. Vaccine Coverage Dutch National Influenza Prevention Program 2021: brief monitor. In: Nivel, editor. 2022.
Frère J, Bidet P, Tapiéro B, Rallu F, Minodier P, Bonacorsi S, et al. Clinical and microbiological characteristics of invasive group A streptococcal infections before and after implementation of a universal varicella vaccine program. Clin Infect Dis. 2016;62(1):75-7. https://doi.org/10.1093/cid/civ793PMID: 26409062
Hasin O, Hazan G, Rokney A, Dayan R, Sagi O, Ben-Shimol S, et al. Invasive group A streptococcus infection in children in Southern Israel before and after the introduction of varicella vaccine. J Pediatric Infect Dis Soc. 2020;9(2):236-9. https://doi.org/10.1093/jpids/piz013PMID: 30927745
Herrera AL, Potts R, Huber VC, Chaussee MS. Influenza enhances host susceptibility to non-pulmonary invasive Streptococcus pyogenes infections. Virulence. 2023;14(1):2265063. https://doi.org/10.1080/21505594.2023.2265063PMID: 37772916
Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023
<p class="citation"><span>Citation style for this article:</span><span class="meta-value authors"><a href="/search?value1=Brechje+de+Gier&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Gier Brechje</a>, <a href="/search?value1=Jan+van+de+Kassteele&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van de Kassteele Jan</a>, <a href="/search?value1=Liselotte+van+Asten&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Asten Liselotte</a>, <a href="/search?value1=Annelot+F+Schoffelen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schoffelen Annelot F</a>, <a href="/search?value1=ISIS-AR+study+group&option1=author&noRedirect=true" class="nonDisambigAuthorLink">ISIS-AR study group</a>, <a href="/search?value1=Mariette+Hooiveld&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hooiveld Mariette</a>, <a href="/search?value1=Margreet+JM+te+Wierik&option1=author&noRedirect=true" class="nonDisambigAuthorLink">te Wierik Margreet JM</a>, <a href="/search?value1=Nina+M+van+Sorge&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Sorge Nina M</a>, <a href="/search?value1=Hester+E+de+Melker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Melker Hester E</a></span>.Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023.<a href="/content/ecdc">Euro Surveill.</a> 2024;29(40):pii=2300739.<a href="https://doi.org/10.2807/1560-7917.ES.2024.29.40.2300739" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2024.29.40.2300739</a><span class="ES_Article_citation"><span class="generated">Received</span>: 21 Dec 2023; <span class="generated">Accepted</span>: 31 Jul 2024 </span></p>
/content/10.2807/1560-7917.ES.2024.29.40.2300739
/content/10.2807/1560-7917.ES.2024.29.40.2300739
Data & Media loading...
Supplementary data
Download
Supplement
Submit comment
Close
Comment moderation successfully completed